Literature DB >> 2916902

Malignant rhabdoid tumor of the kidney and soft tissues. Evidence for a diverse morphological and immunocytochemical phenotype.

M Tsokos1, G Kouraklis, R S Chandra, B S Bhagavan, T J Triche.   

Abstract

Three malignant rhabdoid tumors of the kidney and two extrarenal rhabdoid tumors of soft tissues were studied by light and electron microscopy and by immunocytochemistry for the expression of keratin, vimentin, desmin, neurofilament triplet proteins, epithelial membrane antigen, myoglobin, and HNK-1 (Leu-7). Electron microscopy revealed the characteristic cytoplasmic whorled filamentous inclusions in all tumors. An epithelial phenotype (presence of cytoplasmic tonofilaments) was observed in two tumors (one renal and one extrarenal); and a focal primitive neural phenotype (cytoplasmic processes with neurosecretory granules), in a renal rhabdoid tumor. Strands of basal lamina were seen in two renal and one extrarenal rhabdoid tumors. Evaluation of basal lamina was more difficult in the third renal rhabdoid tumor, in which tissue preservation was not optimal. Primitive attachments were present in all rhabdoid tumors. Immunocytochemical staining supported a diverse phenotype, ranging from epithelial and/or mesenchymal to myogenous and/or neuroectodermal. Simultaneous expression of several of the studied antigenic determinants by the same tumor was noted. The findings suggest that both renal and extrarenal rhabdoid tumors express a diverse morphological and immunocytochemical phenotype.

Entities:  

Mesh:

Year:  1989        PMID: 2916902

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

1.  Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.

Authors:  P Dias; D M Parham; D N Shapiro; B L Webber; P J Houghton
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  Primary congenital rhabdoid tumor of the brain with neoplastic hydranencephaly.

Authors:  M E Velasco; J A Brown; J Kini; E S Ruppert
Journal:  Childs Nerv Syst       Date:  1993-06       Impact factor: 1.475

3.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood.

Authors:  L B Rorke; R Packer; J Biegel
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

4.  Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice.

Authors:  Jessica DelBove; Yasumichi Kuwahara; E Lorena Mora-Blanco; Virginia Godfrey; William K Funkhouser; Christopher D M Fletcher; Terry Van Dyke; Charles W M Roberts; Bernard E Weissman
Journal:  Mol Carcinog       Date:  2009-12       Impact factor: 4.784

5.  Malignant rhabdoid tumour of the uterus: an immunohistochemical and ultrastructural study.

Authors:  M G Cattani; G Viale; D Santini; G N Martinelli
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  Surgery and actinomycin improve survival in malignant rhabdoid tumor.

Authors:  Ryan Horazdovsky; J Carlos Manivel; Edward Y Cheng
Journal:  Sarcoma       Date:  2013-02-03

7.  The autocrine loop of epidermal growth factor receptor-epidermal growth factor / transforming growth factor-alpha in malignant rhabdoid tumor cell lines: heterogeneity of autocrine mechanism in TTC549.

Authors:  T Narita; T Taga; K Sugita; S Nakazawa; S Ohta
Journal:  Jpn J Cancer Res       Date:  2001-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.